TScan Therapeutics, Inc. ( TCRX) - Stock Earnings
TCRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -35.7 million USD | 2.5 million USD |
| 2025Q4 | -23.0 million USD | 2.6 million USD |
| 2026Q1 | -28.7 million USD | 982000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TCRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -89.2 million USD | 21.0 million USD |
| 2024 | -127.5 million USD | 2.8 million USD |
| 2025 | -129.8 million USD | 10.3 million USD |
| 2026 Est. | — | — |
TCRX
Price: $0.92
52 week price:
Earnings Per Share: -0.96 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 133500
Market Capitalization: 60.0 million